Can-Fite BioPharma Ltd. CANF
Set alert
1.63 USD +0.01 +0.62%
At close
1.63 0.00 0.00%
Pre-market · Nov 3, 4:00 AM ET
1.61 Day range 1.66
1.60 52-week range 12.40
- YTD
- -59.25%
- 1 year
- -80.60%
- Open
- 1.62
- Prev close
- 1.62
- Mkt cap
- 4.94M
- Vol
- 33.67K
- Avg vol
- 376.38K
- EPS
- -13.23
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.61
- High
- 1.66
- Forward P/E
- -2.00
- Beta
- 0.57
- Short ratio
- 1.96
- Inst. own
- 8.02%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.08
- 200-d avg
- 2.37
- 1y target
- 14.00
6M chart
Signals (39)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Nov 2, 2026 | 18 hours ago |
| MACD: Sell Signal | Oct 28, 2026 | 5 days ago |
| RSI: Oversold | Oct 23, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 19, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 16, 2026 | 2 weeks ago |
| RSI: Oversold | Oct 8, 2026 | 3 weeks ago |
| MACD: Buy Signal | Sep 24, 2026 | 1 month ago |
| RSI: Oversold | Sep 23, 2026 | 1 month ago |
| SMA: Bearish | Sep 2, 2026 | 2 months ago |
| RSI: Oversold | Sep 2, 2026 | 2 months ago |
| SMA: Bullish | Sep 1, 2026 | 2 months ago |
| SMA: Bearish | Aug 31, 2026 | 2 months ago |
| SMA: Bearish | Aug 31, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 24, 2026 | 2 months ago |
| SMA: Bullish | Aug 6, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 6, 2026 | 2 months ago |
| SMA: Bearish | Jul 31, 2026 | 3 months ago |
| SMA: Bearish | Jul 31, 2026 | 3 months ago |
| SMA: Bullish | Jul 30, 2026 | 3 months ago |
| SMA: Bullish | Jul 30, 2026 | 3 months ago |
Newest 20 of 39.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 14.00 +758.9% upside
Now 1.63
- Target (low)
- 10.00
- Target (mean)
- 14.00
- Target (high)
- 18.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy1
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
- 1 month ago 3
- 2 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 150.00K | -23.5% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 150.00K | -23.5% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 500.00K | -32.7% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 20.00M | +3900.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 5, 2024 | D. Boral Capital | Maintained | Buy | Buy |
| Nov 12, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 17, 2024 | EF Hutton | Initiated | — | Buy |
| May 9, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 24, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jun 2, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Mar 13, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |